I R O G Canada, Inc

SHERPA: Unknown

People

  1. Aghajanian
    Aghajanian
  2. Hensley
    Hensley
  3. Iasonos
    Iasonos
  4. Konner
    Konner
  5. Leitao
    Leitao
  6. Park
    Park
  7. Sabbatini
    Sabbatini
  8. Tew
    Tew

Groups

  1. Biostatistics Service (1)
  2. Department of Medicine (1)
  3. Department of Pathology and Laboratory Medicine (1)
  4. Epidemiology and Biostatistics (1)
  5. GDMT, Medicine (1)
  6. GDMT, Pathology and Laboratory Medicine (1)
  7. GDMT, Surgery (1)
  8. Gynecologic Medicine Service (1)
  9. Gynecology Disease Management Team (1)
  10. Josie Robertson Surgery Center (1)
Search Within
  1. "Department of Pathology and Laboratory Medicine"
Formats
  1. Journal Article (1)
Groups
  1. Biostatistics Service (1)
  2. Department of Medicine (1)
  3. Department of Pathology and Laboratory Medicine (1)
  4. Epidemiology and Biostatistics (1)
  5. GDMT, Medicine (1)
  6. GDMT, Pathology and Laboratory Medicine (1)

More Groups

People
  1. Alexia Iasonos (1)
  2. Carol Aghajanian (1)
  3. Jason Konner (1)
  4. Kay Park (1)
  5. Margrit Juretzka (1)
  6. Mario Leitao (1)

More People

Years
  1. 2008 (1)
Publications
  1. European Journal of Gynaecological Oncology (1)

Results (1)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase 2 trial of oral imatinib in patients with epithelial ovarian, fallopian tube, or peritoneal carcinoma in second or greater remission
    Journal Article

    Juretzka, M.; Hensley, M. L.; Tew, W.; Konner, J.; Aghajanian, C.; Leitao, M.; Iasonos, A.; Soslow, R.; Park, K.; Sabbatini, P.
    European Journal of Gynaecological Oncology (2008)

    Fulltext@MSK | Save

    • I R O G Canada, Inc – authorized name for: